• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday

    9/20/22 3:16:21 AM ET
    $AEHL
    $ALLK
    $ALR
    $APDN
    Building Materials
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AEHL alert in real time by email

    Gainers

    • Ventoux CCM Acquisition Corp. (NASDAQ:VTAQ) shares jumped 54.6% to settle at $7.05 on Monday.
    • Purple Innovation, Inc. (NASDAQ:PRPL) shares surged 39.4% to close at $3.89 after the company confirmed that it received an unsolicited, non-binding proposal from Coliseum Capital Management to acquire all of the outstanding capital stock of Purple for $4.35 per share.
    • Troika Media Group, Inc. (NASDAQ:TRKA) gained 33.3% to close at $0.4021.
    • BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) rose 32.5% to close at $2.95 after the company announced it has signed a share purchase agreement to acquire 100% ownership of Zigi Carmel Initiatives & Investments for $28 million in stock.
    • KnowBe4, Inc. (NASDAQ:KNBE) gained 28.2% to close at $22.17 after the company confirmed it received a non-binding proposal from Vista Equity Partners Management to acquire all of the outstanding shares of the company for $24 per share.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) gained 28.1% to close at $0.2370.
    • Allakos Inc. (NASDAQ:ALLK) rose 27.5% to settle at $5.84 after the company priced an underwritten offering of roughly 29.88 million shares of common stock at $5.02 per share.
    • Winc, Inc. (NYSE:WBEV) gained 26.8% to close at $0.90. Winc, last month, posted a Q2 loss of $0.32 per share
    • Tiziana Life Sciences Ltd (NASDAQ:TLSA) rose 24.8% to close at $0.6862. Tiziana Life Sciences recently announced purchase of 29,318 common shares by Executive Chairman.
    • Marpai, Inc. (NASDAQ:MRAI) gained 22.5% to settle at $1.17.
    • AlerisLife Inc. (NASDAQ:ALR) jumped 19.8% to close at $1.33. AlerisLife announced the appointment of Heather Pereira as Senior Vice President, CFO and Treasurer.
    • ShiftPixy, Inc. (NASDAQ:PIXY) jumped 19.5% to close at $24.12.
    • Coeur Mining, Inc. (NYSE:CDE) gained 17.5% to close at $3.35. Coeur announced agreement to sell Southern Nevada Holdings for upfront cash consideration of $150 million, and deferred cash consideration of $50 million.
    • Sharecare, Inc. (NASDAQ:SHCR) rose 17.4% to settle at $1.96 after the company received three-year Wellness and Health Promotion Accreditation by the National Committee for Quality Assurance for its lifestyle and disease management interventions.
    • Mega Matrix Corp. (NYSE:MTMT) gained 16.7% to close at $1.40.
    • Wix.com Ltd. (NYSE:WIX) jumped 15.7% to settle at $85.26 after Starboard Value disclosed a 9% active stake in the company.
    • Mill City Ventures III, Ltd. (NASDAQ:MCVT) gained 14.7% to close at $2.11.
    • Studio City International Holdings Limited (NYSE:MSC) surged 13.3% to settle at $2.04.
    • Secoo Holding Limited (NASDAQ:SECO) rose 13.2% to settle at $0.3972. Aladdin Technology Group recently agreed to invest RMB1.3 million in the company.
    • VEON Ltd. (NASDAQ:VEON) rose 13.1% to close at $0.4071 after dropping 18% on Friday. VEON Group’s consolidated revenue rose 3.1% year-on-year for the first eight months of 2022.
    • Nordic American Tankers Limited (NYSE:NAT) gained 12.9% to close at $3.51.
    • Celularity Inc. (NASDAQ:CELU) rose 12.7% to settle at $2.39. Celularity recently announced a $40 million common stock offering.
    • 1847 Holdings LLC (NYSE:EFSH) gained 12.6% to close at $2.2962.
    • Teekay Tankers Ltd. (NYSE:TNK) rose 12.5% to settle at $31.01.
    • Versus Systems Inc. (NASDAQ:VS) rose 12.2% to close at $0.2514.
    • Innovative Industrial Properties, Inc. (NYSE:IIPR) gained 11.9% to settle at $102.31 as Compass Point upgraded the stock from Neutral to Buy and raised its price target from $100 to $175.
    • Vista Gold Corp. (NYSE:VGZ) gained 11.3% to close at $0.54.
    • IceCure Medical Ltd (NASDAQ:ICCM) gained 10.7% to close at $1.55. IceCure recently submitted regulatory filing in Vietnam for approval of ProSense.
    • Nauticus Robotics, Inc. (NASDAQ:KITT) rose 10.3% to settle at $7.17. Schlumberger B.V. disclosed a 15.5% passive stake in Nauticus Robotics.
    • XPeng Inc. (NYSE:XPEV) gained 7.4% to close at $15.64. XPeng launched the pilot program of City Navigation Guided Pilot (City NGP).


    Losers

    • Virios Therapeutics, Inc. (NASDAQ:VIRI) shares fell 77.2% to close at $2.00 on Monday after the company announced top-line results from a Phase 2b study of IMC-1 in fibromyalgia, saying the "study did not achieve statistical significance on the prespecified primary efficacy endpoint of change."
    • MicroCloud Hologram Inc. (NASDAQ:HOLO) shares dipped 64.9% to close at $2.95 on Monday.
    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) dropped 46.1% to close at $0.3127 after jumping 53% on Friday. Panbela Therapeutics recently filed for public offering of 28.9 million shares of common stock and common stock purchase warrants.
    • FOXO Technologies Inc. (NYSE:FOXO) dropped 37.8% to close at $2.50.
    • Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) declined 37% to close at $1.72. Sonnet BioTherapeutics reported a 1-for-14 reverse stock split.
    • BioLineRx Ltd. (NASDAQ:BLRX) fell 35% to close at $1.02 after the company announced a $15 million registered direct offering.
    • Wag! Group Co. (NASDAQ:PET) dropped 34.8% to settle at $3.50.
    • Sotera Health Company (NASDAQ:SHC) declined 33.3% to close at $9.83.
    • Amprius Technologies, Inc. (NYSE:AMPX) fell 28.9% to settle at $5.90.
    • Locafy Limited (NASDAQ:LCFY) dropped 27.4% to settle at $0.4116.
    • Connexa Sports Technologies Inc. (NASDAQ:CNXA) fell 25% to close at $0.4651.
    • Nexalin Technology, Inc. (NASDAQ:NXL) shares declined 24.9% to close at $1.69 after tumbling 45% on Friday. Nexalin Technology priced its IPO at $4.15 per share.
    • BriaCell Therapeutics Corp. (NASDAQ:BCTX) dipped 23% to settle at $6.17.
    • Inozyme Pharma, Inc. (NASDAQ:INZY) fell 22.7% to close at $3.03. Inozyme Pharma, last month, posted a Q2 loss of $0.38 per share.
    • Wearable Devices Ltd. (NASDAQ:WLDS) dropped 22.7% to close at $1.81.
    • Nabriva Therapeutics plc (NASDAQ:NBRV) declined 21.2% to close at $3.01.
    • Grove Collaborative Holdings, Inc. (NYSE:GROV) fell 21.1% to $5.49.
    • E-Home Household Service Holdings Limited (NASDAQ:EJH) dropped 20.3% to close at $0.1550 after the company announced a share purchase agreement with White Lion Capital for up to $12.3 million.
    • Applied DNA Sciences, Inc. (NASDAQ:APDN) fell 19.3% to close at $1.8250.
    • Forge Global Holdings, Inc. (NYSE:FRGE) dropped 19.2% to close at $2.87.
    • Twin Vee Powercats Co. (NASDAQ:VEEE) fell 19.2% to settle at $3.24.
    • Antelope Enterprise Holdings Limited (NASDAQ:AEHL) fell 19% to close at $0.64.
    • Regis Corporation (NYSE:RGS) fell 18.8% to close at $1.04. Regis recently posted a Q4 loss of $0.07 per share.
    • Veru Inc. (NASDAQ:VERU) fell 18.1% to close at $11.69.
    • Greenwave Technology Solutions, Inc. (NASDAQ:GWAV) fell 18% to close at $2.10. Greenwave Technology Solutions said on Sept. 12, 2022, the company terminated employment of Chief Financial Officer Howard Jordan. It hired Ashley Sickles as new CFO.
    • iBio, Inc. (NYSE:IBIO) fell 17.4% to close at $0.38 after jumping around 50% on Friday.
    • Athersys, Inc. (NASDAQ:ATHX) dropped 17.4% to close at $1.61.
    • Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) declined 17.3% to settle at $6.08. Syros Pharmaceuticals and Tyme Technologies recently announced stockholder approval of the merger agreement.
    • Valneva SE (NASDAQ:VALN) fell 16.7% to close at $13.45. Valneva and IDT Biologika agreed on termination of their COVID-19 collaboration.
    • Innate Pharma S.A. (NASDAQ:IPHA) shares fell 15.6% to close at $2.59. Innate Pharma recently reported H1 sales of €45.6 million up from €14.67 million year over year.
    • Recruiter.com Group, Inc. (NYSE:RCRT) dropped 15.6% to close at $1.14. Recruiter.com Group filed for mixed-securities shelf offering of up to $100 million, Reuters reported.
    • Hempacco Co., Inc. (NASDAQ:HPCO) fell 15.1% to close at $2.41 amid post-IPO volatility.
    • AMTD Digital Inc. (NYSE:HKD) fell 14.8% to close at $92.00.
    • Akili, Inc. (NASDAQ:AKLI) declined 14% to close at $3.37.
    • D-Wave Quantum Inc. (NYSE:QBTS) fell 13.6% to settle at $5.74.
    • SoundHound AI, Inc. (NASDAQ:SOUN) fell 13.4% to close at $3.24 following a 15% surge on Friday.
    • Minerva Surgical, Inc. (NASDAQ:UTRS) fell 12.9% to close at $0.88.
    • Axcella Health Inc. (NASDAQ:AXLA) declined 12.5% to close at $2.11.
    • Innovid Corp. (NYSE:CTV) declined 11.7% to close at $2.34.
    • Heliogen, Inc. (NYSE:HLGN) fell 11.3% to close at $1.97.
    • Pagaya Technologies Ltd. (NASDAQ:PGY) declined 11.2% to close at $6.99.
    • Design Therapeutics, Inc. (NASDAQ:DSGN) dropped 11% to close at $19.39.
    • Nikola Corporation (NASDAQ:NKLA) fell 10.6% to close at $4.58 after CNBC's Jim Cramer recently made bearish comments on the stock.
    • Lannett Company, Inc. (NYSE:LCI) fell 9.6% to close at $0.5201 after surging 25% on Friday. Lannett Company recently reported Q4 FY22 sales of $74.2 million, down from $106 million a year ago.
    • ImmunityBio, Inc. (NASDAQ:IBRX) declined 9.1% to close at $5.51.
    • Moderna, Inc. (NASDAQ:MRNA) dropped 7.1% to close at $127.90. Moderna’s COVID-19 vaccine would be used in a World Health Organization effort to develop mRNA shots to increase production and access for developing countries, Bloomberg reported.
    • Super Micro Computer, Inc. (NASDAQ:SMCI) fell 7% to close at $57.97. Susquehanna downgraded Super Micro Computer from Positive to Neutral.
    • Dynavax Technologies Corporation (NASDAQ:DVAX) dropped 6.6% to close at $10.63.
    • bluebird bio, Inc. (NASDAQ:BLUE) fell 6.5% to close at $5.93. bluebird bio disclosed that the Food and Drug Administration approved its gene therapy for a rare neurodegenerative disease.
    Get the next $AEHL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEHL
    $ALLK
    $ALR
    $APDN

    CompanyDatePrice TargetRatingAnalyst
    Teekay Tankers Ltd.
    $TNK
    2/20/2026Buy → Hold
    DNB Markets
    Coeur Mining Inc.
    $CDE
    2/20/2026Buy → Hold
    Canaccord Genuity
    D-Wave Quantum Inc.
    $QBTS
    2/12/2026Buy
    TD Cowen
    Moderna Inc.
    $MRNA
    1/28/2026$25.00Equal Weight
    Barclays
    Super Micro Computer Inc.
    $SMCI
    1/13/2026$26.00Sell
    Goldman
    Sotera Health Company
    $SHC
    1/9/2026$24.00Neutral → Overweight
    Piper Sandler
    Sotera Health Company
    $SHC
    1/9/2026$24.00Outperform
    RBC Capital Mkts
    Moderna Inc.
    $MRNA
    1/7/2026$34.00Neutral
    UBS
    More analyst ratings

    $AEHL
    $ALLK
    $ALR
    $APDN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Teekay Tankers downgraded by DNB Markets

    DNB Markets downgraded Teekay Tankers from Buy to Hold

    2/20/26 8:23:03 AM ET
    $TNK
    Marine Transportation
    Consumer Discretionary

    Coeur Mining downgraded by Canaccord Genuity

    Canaccord Genuity downgraded Coeur Mining from Buy to Hold

    2/20/26 8:21:45 AM ET
    $CDE
    Precious Metals
    Basic Materials

    TD Cowen initiated coverage on D-Wave Quantum

    TD Cowen initiated coverage of D-Wave Quantum with a rating of Buy

    2/12/26 7:24:12 AM ET
    $QBTS
    EDP Services
    Technology

    $AEHL
    $ALLK
    $ALR
    $APDN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for LEVOFLOXACIN issued to LANNETT CO INC

    Submission status for LANNETT CO INC's drug LEVOFLOXACIN (SUPPL-11) with active ingredient LEVOFLOXACIN has changed to 'Approval' on 09/20/2024. Application Category: ANDA, Application Number: 205222, Application Classification: Labeling

    9/24/24 4:39:48 AM ET
    $LCI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for MYCOPHENOLATE MOFETIL issued to LANNETT CO INC

    Submission status for LANNETT CO INC's drug MYCOPHENOLATE MOFETIL (SUPPL-7) with active ingredient MYCOPHENOLATE MOFETIL has changed to 'Approval' on 08/13/2024. Application Category: ANDA, Application Number: 214525, Application Classification: REMS

    8/15/24 4:43:42 AM ET
    $LCI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE issued to LANNETT CO INC

    Submission status for LANNETT CO INC's drug SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE (ORIG-1) with active ingredient MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE has changed to 'Approval' on 07/15/2024. Application Category: ANDA, Application Number: 209941, Application Classification:

    7/17/24 4:37:21 AM ET
    $LCI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEHL
    $ALLK
    $ALR
    $APDN
    SEC Filings

    View All

    iBio Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - iBio, Inc. (0001420720) (Filer)

    2/27/26 4:49:58 PM ET
    $IBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-3 filed by iBio Inc.

    S-3 - iBio, Inc. (0001420720) (Filer)

    2/27/26 4:23:59 PM ET
    $IBIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Twin Vee PowerCats Co.

    10-K - Twin Vee PowerCats, Co. (0001855509) (Filer)

    2/27/26 4:09:22 PM ET
    $VEEE
    Marine Transportation
    Industrials

    $AEHL
    $ALLK
    $ALR
    $APDN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Simon Barry J. sold $900,788 worth of shares (75,000 units at $12.01), decreasing direct ownership by 3% to 2,850,821 units (SEC Form 4)

    4 - ImmunityBio, Inc. (0001326110) (Issuer)

    2/26/26 8:12:26 PM ET
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Swets Larry G Jr bought $47,000 worth of shares (100,000 units at $0.47) (SEC Form 4)

    4 - Twin Vee PowerCats, Co. (0001855509) (Issuer)

    2/25/26 5:02:06 PM ET
    $VEEE
    Marine Transportation
    Industrials

    SEC Form 3 filed by new insider Swets Larry G Jr

    3 - Twin Vee PowerCats, Co. (0001855509) (Issuer)

    2/25/26 5:01:37 PM ET
    $VEEE
    Marine Transportation
    Industrials

    $AEHL
    $ALLK
    $ALR
    $APDN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    With TGE Consolidated, AMTD Digital Reports Full Year Results with 565.7% Increase in Revenue, 132.7% Increase in Net Income, and 280.2% Increase in Net Assets

    PARIS and NEW YORK and LONDON, Feb. 27, 2026 /PRNewswire/ -- AMTD Digital Inc. ("AMTD Digital" or the "Company") (NYSE:HKD), a NYSE-listed company and a subsidiary of AMTD Group Inc., today announced the filing of its annual report on Form 20-F for the fiscal year ended October 31, 2025 with the Securities and Exchange Commission, which consolidates the financial results of The Generation Essentials Group (", TGE", , NYSE:TGE, LSE: TGE);  summary highlights below: Total Revenue increased by 565.7% from US$20.4 million to US$136.1 millionTotal Net Income increased by 132.7% from US$41.7 million to US$97.0 million Total Assets amounted to US$955.4 million (US$7.57/share)Net asset value amounte

    2/27/26 4:28:00 PM ET
    $AMTD
    $HKD
    $TGE
    Finance: Consumer Services
    Finance
    Newspapers/Magazines
    Consumer Discretionary

    AMTD IDEA's Subsidiary AMTD Digital Reports Full Year Results with 565.7% Increase in Revenue, 132.7% Increase in Net Income, and 280.2% Increase in Net Assets

    PARIS and NEW YORK and LONDON, Feb. 27, 2026 /PRNewswire/ -- AMTD IDEA (NYSE:AMTD, SGX: HKB)) subsidiary AMTD Digital Inc. (NYSE:HKD), a NYSE‑listed company and subsidiary of AMTD Group Inc., today announced it has filed its annual report on Form 20‑F with the U.S. Securities and Exchange Commission for the fiscal year ended October 31, 2025. Summary highlights are below: Total Revenue increased by 565.7% from US$20.4 million to US$136.1 millionTotal Net Income increased by 132.7% from US$41.7 million to US$97.0 million Total Assets amounted to US$955.4 million (US$7.57/share)Net asset value amounted to US$603.7 million (US$4.78/share)The annual report is available on AMTD Digital's investor

    2/27/26 4:27:00 PM ET
    $AMTD
    $HKD
    Finance: Consumer Services
    Finance

    AMTD Digital Reports Full Year Results with 565.7% Increase in Revenue, 132.7% Increase in Net Income, and 280.2% Increase in Net Assets

    PARIS and NEW YORK and LONDON, Feb. 27, 2026 /PRNewswire/ -- AMTD Digital Inc. ("AMTD Digital" or the "Company") (NYSE:HKD), a NYSE-listed company and a subsidiary of AMTD Group Inc., today announced the filing of its annual report on Form 20-F for the fiscal year ended October 31, 2025 with the Securities and Exchange Commission, with summary highlights below: Total Revenue increased by 565.7% from US$20.4 million to US$136.1 millionTotal Net Income increased by 132.7% from US$41.7 million to US$97.0 million Total Assets amounted to US$955.4 million (US$7.57/share)Net asset value amounted to US$603.7 million (US$4.78/share)The annual report is available on the Company's investor relations w

    2/27/26 4:25:00 PM ET
    $HKD
    Finance: Consumer Services
    Finance

    $AEHL
    $ALLK
    $ALR
    $APDN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Swets Larry G Jr bought $47,000 worth of shares (100,000 units at $0.47) (SEC Form 4)

    4 - Twin Vee PowerCats, Co. (0001855509) (Issuer)

    2/25/26 5:02:06 PM ET
    $VEEE
    Marine Transportation
    Industrials

    CEO & Interim CFO Visconti Joseph C bought $9,400 worth of shares (20,000 units at $0.47), increasing direct ownership by 8% to 262,914 units (SEC Form 4)

    4 - Twin Vee PowerCats, Co. (0001855509) (Issuer)

    2/25/26 5:01:09 PM ET
    $VEEE
    Marine Transportation
    Industrials

    EXECUTIVE CHAIRMAN Gold Alan D bought $127,634 worth of shares (2,600 units at $49.09) (SEC Form 4)

    4 - INNOVATIVE INDUSTRIAL PROPERTIES INC (0001677576) (Issuer)

    11/25/25 7:52:40 PM ET
    $IIPR
    Real Estate
    Finance

    $AEHL
    $ALLK
    $ALR
    $APDN
    Financials

    Live finance-specific insights

    View All

    ImmunityBio to Provide a Business Update and Review Financial Results for FY 2025 on Tuesday, March 3, 2026

    ImmunityBio, Inc. ((IBRX), today announced that it will host a live conference call at 1:30 p.m. Pacific Time on Tuesday, March 3, 2026, to provide a business update, including progress across the company's clinical trial pipeline, and to review financial results for the year ended December 31, 2025. Conference Call Details The conference call will begin at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) on Tuesday, March 3, 2026. Interested parties may access the conference call through our Investor Relations website, ir.immunitybio.com, under Company — Events & Presentations. Alternatively, individuals can access the call by dialing 1-844-539-3703 or 1-412-652-1273 (internationally).

    2/27/26 7:30:00 AM ET
    $IBRX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SoundHound AI Reports Record Annual Revenue of $169 Million, Up Nearly 100%, Forecasts Strong Growth

    SANTA CLARA, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- SoundHound AI, Inc. (NASDAQ:SOUN), a global leader in voice and conversational AI, today reported its financial results for the fourth quarter and full year 2025. "As traditional software faces massive AI disruption, businesses are looking to partner with AI natives that can help them achieve success in a new era. This is creating strong tailwinds for SoundHound," said Keyvan Mohajer, CEO and Co-Founder of SoundHound AI. "Our results speak for themselves. All key profit metrics were up and in the last quarter we closed a record number of customer deals as we capitalized on the surge in demand for enterprise-grade AI." Financial Hig

    2/26/26 4:06:00 PM ET
    $SOUN
    Computer Software: Prepackaged Software
    Technology

    D-Wave Reports Fourth Quarter and Year-End 2025 Results

    FY 2025 Revenue Increased 179% Year over Year FY 2025 Gross Profit Increased 265% Year over Year Ended 2025 With Highest Liquidity Position in Company's History at over $884 Million D-Wave Quantum Inc. (NYSE:QBTS) ("D-Wave" or the "Company"), the only dual-platform quantum computing company, providing both annealing and gate-model systems, software, and services, today announced financial results for its fiscal fourth quarter and year ended December 31, 2025. "Our 2025 results mark one of the most successful and transformative years in D-Wave's history, with meaningful growth across every key business metric — revenue, Bookings, technical milestones, and scientific breakthroughs," s

    2/26/26 7:00:00 AM ET
    $QBTS
    EDP Services
    Technology

    $AEHL
    $ALLK
    $ALR
    $APDN
    Leadership Updates

    Live Leadership Updates

    View All

    Tectonic Therapeutic Appoints François Nader, M.D., as Chair and Independent Director of the Board

    WATERTOWN, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ:TECX) ("Tectonic"), a clinical-stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-protein coupled receptors (GPCRs), today announced it has appointed François Nader, M.D., MBA, as an independent director to its Board of Directors, effective April 1, 2026, at which time he will also assume the role of Chair of the Board. Dr. Nader brings more than 30 years of leadership experience across the biotechnology and pharmaceutical industry and currently serves as an Independent Director of Moderna, Inc. (NASDAQ:MRNA), a glo

    2/23/26 4:01:00 PM ET
    $MRNA
    $TECX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    D-Wave Joins Southeastern Quantum Collaborative as Inaugural Member

    D-Wave Quantum Inc. (NYSE:QBTS) ("D-Wave" or the "Company"), the only dual-platform quantum computing company, providing both annealing and gate-model systems, software and services, today joined the Southeastern Quantum Collaborative (SQC) as an inaugural member, along with The University of Alabama in Huntsville, Davidson Technologies, IBM and Alabama A&M University. The SQC will bring together academia, industry and government to accelerate the advancement and application of quantum information science and technology across the Southeast. In addition, it aims to develop the quantum-ready workforce needed to commercialize the technology. Given Davidson hosts a D-Wave Advantage2TM system

    2/19/26 7:00:00 AM ET
    $QBTS
    EDP Services
    Technology

    Greenwave Announces Appointment of Chelsea Pullano as Chief Financial Officer

    Chesapeake, VA, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Greenwave Technology Solutions, Inc. ("Greenwave" or the "Company") (NASDAQ:GWAV), an operator of metal recycling facilities in Virginia, North Carolina, and Ohio, today announced that the board of directors ("Board") of the Company appointed Chelsea Pullano as Chief Financial Officer of the Company, effective February 5, 2026. Ms. Pullano's appointment is in connection with the Company's entry into the scope of work agreement with MACK Financial Solutions, LLC ("MACK"), dated January 2, 2026, pursuant to which MACK agreed to provide professional services to the Company, including oversight of all bookkeeping, financial reporting and SEC r

    2/10/26 4:15:00 PM ET
    $GWAV
    Metal Fabrications
    Industrials

    $AEHL
    $ALLK
    $ALR
    $APDN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by BriaCell Therapeutics Corp.

    SC 13D/A - BriaCell Therapeutics Corp. (0001610820) (Subject)

    12/12/24 6:06:07 AM ET
    $BCTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by BriaCell Therapeutics Corp.

    SC 13D/A - BriaCell Therapeutics Corp. (0001610820) (Subject)

    12/10/24 6:06:45 AM ET
    $BCTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Marpai Inc.

    SC 13D/A - Marpai, Inc. (0001844392) (Subject)

    12/9/24 5:14:07 PM ET
    $MRAI
    Misc Health and Biotechnology Services
    Health Care